Using disease mode of action-based profiling for cohort identification simply means you can find the unique characteristics of a specific patient population and use that information to secure participation in the right trials.

These crucial decisions can identify subsets of patients with particular clinical attributes that can proactively stratify patients on the basis of risk factors. Biovista can help develop a predictive decision support environment to enable clinical researchers to rapidly discover the factors that influence specific disease outcomes and drug safety risk profiles. This environment is able to support the needs of clinicians, disease biologists and clinical research teams in a single platform and is applicable to any disease study.

For more information on our Cohort Identification service please contact us.